Intel (INTC) 10-Q27 Apr 232023 Q1 Quarterly reportFinancial data

Company Profile

Cover Page

Cover Page - shares shares in Millions	3 Months Ended
Cover Page - shares shares in Millions	Apr. 01, 2023	Apr. 21, 2023
Cover [Abstract]
Document Type	10-Q
Document Quarterly Report	true
Document Transition Report	false
Document Period End Date	Apr. 01, 2023
Entity File Number	000-06217
Entity Registrant Name	INTEL CORPORATION
Entity Central Index Key	0000050863
Current Fiscal Year End Date	--12-31
Document Fiscal Year Focus	2023
Document Fiscal Period Focus	Q1
Amendment Flag	false
Entity Incorporation, State or Country Code	DE
Entity Tax Identification Number	94-1672743
Entity Address, Address Line One	2200 Mission College Boulevard,
Entity Address, City or Town	Santa Clara,
Entity Address, State or Province	CA
Entity Address, Postal Zip Code	95054-1549
City Area Code	(408)
Local Phone Number	765-8080
Title of 12(b) Security	Common stock, $0.001 par value
Trading Symbol	INTC
Security Exchange Name	NASDAQ
Entity Current Reporting Status	Yes
Entity Interactive Data Current	Yes
Entity Filer Category	Large Accelerated Filer
Entity Small Business	false
Entity Emerging Growth Company	false
Entity Shell Company	false
Entity Common Stock, Shares Outstanding		4,171

Consolidated Condensed Statemen

Consolidated Condensed Statements of Income - USD ($) shares in Millions, $ in Millions	3 Months Ended
	Apr. 01, 2023	Apr. 02, 2022
Income Statement [Abstract]
Net revenue	$ 11,715	$ 18,353
Cost of sales	7,707	9,109
Gross margin	4,008	9,244
Research and development	4,109	4,362
Marketing, general, and administrative	1,303	1,752
Restructuring and other charges	64	(1,211)
Operating expenses	5,476	4,903
Operating income (loss)	(1,468)	4,341
Gains (losses) on equity investments, net	169	4,323
Interest and other, net	141	997
Income (loss) before taxes	(1,158)	9,661
Provision for taxes	1,610	1,548
Net income (loss)	(2,768)	8,113
Less: Net income (loss) attributable to non-controlling interests	(10)	0
Net income (loss) attributable to Intel	$ (2,758)	$ 8,113
Earnings per share - Basic (in dollars per share)	$ (0.66)	$ 1.99
Earnings per share - Diluted (in dollars per share)	$ (0.66)	$ 1.98
Weighted average shares of common stock outstanding:
Basic (shares)	4,154	4,079
Diluted (shares)	4,154	4,107

Consolidated Condensed Statem_2

Consolidated Condensed Statements of Comprehensive Income - USD ($) $ in Millions	3 Months Ended
	Apr. 01, 2023	Apr. 02, 2022
Statement of Comprehensive Income [Abstract]
Net income (loss)	$ (2,768)	$ 8,113
Changes in other comprehensive income, net of tax:
Net unrealized holding gains (losses) on derivatives	142	(115)
Actuarial valuation and other pension benefits (expenses), net	1	18
Translation adjustments and other	0	(25)
Other comprehensive income (loss)	143	(122)
Total comprehensive income (loss)	(2,625)	7,991
Less: comprehensive income (loss) attributable to non-controlling interests	(10)	0
Total comprehensive income (loss)	$ (2,615)	$ 7,991

Consolidated Condensed Balance

Consolidated Condensed Balance Sheets - USD ($) $ in Millions	Apr. 01, 2023	Dec. 31, 2022
Current assets:
Cash and cash equivalents	$ 8,232	$ 11,144
Short-term investments	19,302	17,194
Accounts receivable, net	3,847	4,133
Inventories	12,993	13,224
Other current assets	3,940	4,712
Total current assets	48,314	50,407
Property, plant and equipment, net of accumulated depreciation of $94,550 ($93,386 as of December 31, 2022)	85,734	80,860
Equity Investments	6,029	5,912
Goodwill	27,591	27,591
Identified intangible assets, net	5,567	6,018
Other long-term assets	12,068	11,315
Total assets	185,303	182,103
Current liabilities:
Short-term debt	1,437	4,367
Accounts payable	8,083	9,595
Accrued compensation and benefits	2,497	4,084
Income taxes payable	4,046	2,251
Other accrued liabilities	11,330	11,858
Total current liabilities	27,393	32,155
Debt	48,836	37,684
Long-term income taxes payable	3,831	3,796
Other long-term liabilities	4,840	5,182
Contingencies (Note 12)
Stockholders’ equity:
Common stock and capital in excess of par value, 4,171 issued and outstanding (4,137 issued and outstanding as of December 31, 2022)	32,829	31,580
Accumulated other comprehensive income (loss)	(419)	(562)
Retained earnings	65,649	70,405
Total stockholders' equity	98,059	101,423
Non-controlling interest	2,344	1,863
Accumulated other comprehensive income (loss)	100,403	103,286
Total liabilities and stockholders’ equity	$ 185,303	$ 182,103

Consolidated Condensed Balanc_2

Consolidated Condensed Balance Sheets (Parenthetical) - USD ($) shares in Millions, $ in Millions	Apr. 01, 2023	Dec. 31, 2022
Assets
Accumulated depreciation	$ 94,550	$ 93,386
Stockholders’ equity:
Common stock, shares issued	4,171	4,137
Common stock, shares outstanding		4,137

Consolidated Condensed Statem_3

Consolidated Condensed Statements of Cash Flows - USD ($) $ in Millions	3 Months Ended
	Apr. 01, 2023	Apr. 02, 2022
Statement of Cash Flows [Abstract]
Cash and cash equivalents, beginning of period	$ 11,144	$ 4,827
Cash flows provided by (used for) operating activities:
Net income (loss)	(2,768)	8,113
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation	1,901	2,847
Share-based compensation	739	707
Restructuring and other charges	55	17
Amortization of intangibles	465	501
(Gains) losses on equity investments, net	(167)	(4,325)
(Gains) losses on divestitures	0	(1,121)
Changes in assets and liabilities:
Accounts receivable	286	2,384
Inventories	231	(1,147)
Accounts payable	(771)	(128)
Accrued compensation and benefits	(1,560)	(1,884)
Income taxes	1,344	1,219
Other assets and liabilities	(1,540)	(1,292)
Total adjustments	983	(2,222)
Net cash provided by operating activities	(1,785)	5,891
Cash flows provided by (used for) investing activities:
Additions to property, plant and equipment	(7,413)	(4,604)
Purchases of short-term investments	(16,132)	(19,091)
Proceeds from Maturities, Prepayments and Calls of Debt Securities, Available-for-sale	14,173	10,490
Sales of equity investments	116	4,682
Proceeds from divestiture	0	6,544
Other investing	735	(660)
Net cash used for investing activities	(8,521)	(2,639)
Cash flows provided by (used for) financing activities:
Repayment of commercial paper	(2,930)	0
Payments on finance leases	(15)	(299)
Partner contributions	449	0
Issuance of long-term debt, net of issuance costs	10,968	0
Proceeds from sales of common stock through employee equity incentive plans	659	589
Payment of dividends to stockholders	(1,512)	(1,487)
Other financing	(225)	(667)
Net cash provided by (used for) financing activities	7,394	(1,864)
Net increase (decrease) in cash and cash equivalents	(2,912)	1,388
Cash and cash equivalents, end of period	8,232	6,215
Supplemental disclosures:
Acquisition of property, plant and equipment included in accounts payable and accrued liabilities	4,711	2,949
Interest, net of capitalized interest	313	177
Income taxes, net of refunds	$ 267	$ 335

Consolidated Condensed Statem_4

Consolidated Condensed Statements of Stockholders' Equity - USD ($) shares in Thousands, $ in Millions	Total	Common Stock and Capital in Excess of Par Value	Accumulated Other Comprehensive Income (Loss)	Retained Earnings	Noncontrolling Interest
Common stock, shares outstanding, beginning (in shares) at Dec. 25, 2021		4,070,000
Total stockholders' equity, beginning at Dec. 25, 2021	$ 95,391	$ 28,006	$ (880)	$ 68,265	$ 0
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income (loss)	8,113			8,113
Other comprehensive income (loss)	(122)		(122)
Employee equity incentive plans and other (in shares)		20,000
Employee equity incentive plans and other	589	$ 589
Share-based compensation	707	$ 707
Restricted stock unit withholdings (in shares)		(1,000)
Restricted stock unit withholdings	(55)	$ (58)		3
Cash dividends declared	(1,487)			(1,487)
Common stock, shares outstanding, ending (in shares) at Apr. 02, 2022		4,089,000
Total stockholders' equity, ending at Apr. 02, 2022	$ 103,136	$ 29,244	(1,002)	74,894	0
Common stock, shares outstanding, beginning (in shares) at Dec. 31, 2022	4,137,000	4,137,000
Total stockholders' equity, beginning at Dec. 31, 2022	$ 103,286	$ 31,580	(562)	70,405	1,863
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income (loss)	(2,768)			(2,758)	(10)
Other comprehensive income (loss)	143		143
Net proceeds received from partner contributions	449				449
Employee equity incentive plans and other (in shares)		36,000
Employee equity incentive plans and other	659	$ 659
Share-based compensation	739	$ 697			42
Restricted stock unit withholdings (in shares)		(2,000)
Restricted stock unit withholdings	(69)	$ (107)		38
Cash dividends declared	(2,036)			(2,036)
Common stock, shares outstanding, ending (in shares) at Apr. 01, 2023		4,171,000
Total stockholders' equity, ending at Apr. 01, 2023	$ 100,403	$ 32,829	$ (419)	$ 65,649	$ 2,344

Consolidated Condensed Statem_5

Consolidated Condensed Statements of Stockholders' Equity (Parenthetical) - $ / shares	3 Months Ended
	Apr. 01, 2023	Apr. 02, 2022
Retained Earnings
Cash dividends declared (in dollars per share)	$ 0.49	$ 0.37

Basis of Presentation

Basis of Presentation	3 Months Ended
Basis of Presentation	Apr. 01, 2023
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Basis of Presentation	Note 1 : Basis of Presentation We prepared our interim Consolidated Condensed Financial Statements that accompany these notes in conformity with US GAAP, consistent in all material respects with those applied in our 2022 Form 10-K. We have a 52- or 53-week fiscal year that ends on the last Saturday in December. Fiscal year 2023 is a 52-week fiscal year; fiscal 2022 was a 53-week fiscal year, with the extra week included in the first quarter of 2022. We have made estimates and judgments affecting the amounts reported in our Consolidated Condensed Financial Statements and the accompanying notes. The actual results that we experience may differ materially from our estimates. The interim financial information is unaudited, and reflects all normal adjustments that are, in our opinion, necessary to provide a fair statement of results for the interim periods presented. This report should be read in conjunction with the Consolidated Financial Statements in our 2022 Form 10-K where we include additional information on our critical accounting estimates, policies, and the methods and assumptions used in our estimates.

Operating Segments

Operating Segments	3 Months Ended
Operating Segments	Apr. 01, 2023
Segment Reporting [Abstract]
Operating Segments	Note 2 : Operating Segments We previously announced the organizational change to integrate AXG into CCG and DCAI. This change is intended to drive a more effective go-to-market capability and to accelerate the scale of these businesses, while also reducing costs. As a result, we modified our segment reporting in the first quarter of 2023 to align to this and certain other business reorganizations. All prior-period segment data has been retrospectively adjusted to reflect the way our CODM internally receives information and manages and monitors our operating segment performance starting in fiscal year 2023. We now manage our business through the following operating segments: ▪ Client Computing (CCG) ▪ Data Center and AI (DCAI) ▪ Network and Edge (NEX) ▪ Mobileye ▪ Intel Foundry Services (IFS) We derive a substantial majority of our revenue from our principal products that incorporate various components and technologies, including a microprocessor and chipset, a stand-alone SoC, or a multichip package, which is based on Intel ® architecture. CCG, DCAI and NEX are our reportable operating segments. Mobileye and IFS do not qualify as reportable operating segments; however, we have elected to disclose the results of these non-reportable operating segments. When we enter into federal contracts, they are aligned to the sponsoring operating segment. We have sales and marketing, manufacturing, engineering, finance, and administration groups. Expenses for these groups are generally allocated to the operating segments. We have an "all other" category that includes revenue, expenses, and charges such as: ▪ results of operations from non-reportable segments not otherwise presented, and from start-up businesses that support our initiatives; ▪ historical results of operations from divested businesses; ▪ amounts included within restructuring and other charges ; ▪ employee benefits, compensation, impairment charges, and other expenses not allocated to the operating segments; and ▪ acquisition-related costs, including amortization and any impairment of acquisition-related intangibles and goodwill. The CODM, who is our CEO, allocates resources to and assesses the performance of each operating segment using information about the operating segment's revenue and operating income (loss). The CODM does not evaluate operating segments using discrete asset information, and we do not identify or allocate assets by operating segments. Based on the interchangeable nature of our manufacturing and assembly and test assets, most of the related depreciation expense is not directly identifiable within our operating segments, as it is included in overhead cost pools and subsequently absorbed into inventory as each product passes through our manufacturing process. Because our products are then sold across multiple operating segments, it is impracticable to determine the total depreciation expense included as a component of each operating segment's operating income (loss) results. We do not allocate gains and losses from equity investments, interest and other income, share-based compensation, or taxes to our operating segments. Although the CODM uses operating income (loss) to evaluate the segments, operating costs included in one segment may benefit other segments. The accounting policies for segment reporting are the same as for Intel as a whole. There have been no changes to our segment accounting policies disclosed in our 2022 Form 10-K except for the organizational change described above. Net revenue and operating income (loss) for each period were as follows: Three Months Ended (In Millions) Apr 1, 2023 Apr 2, 2022 Net revenue: Client Computing Desktop $ 1,879 $ 2,641 Notebook 3,407 5,959 Other 481 722 5,767 9,322 Data Center and AI 3,718 6,074 Network and Edge 1,489 2,139 Mobileye 458 394 Intel Foundry Services 118 156 All other 165 268 Total net revenue $ 11,715 $ 18,353 Operating income (loss): Client Computing $ 520 $ 2,722 Data Center and AI (518) 1,393 Network and Edge (300) 416 Mobileye 123 148 Intel Foundry Services (140) (23) All other (1,153) (315) Total operating income (loss) $ (1,468) $ 4,341

Non-Controlling Interests

Non-Controlling Interests	3 Months Ended
Non-Controlling Interests	Apr. 01, 2023
Noncontrolling Interest [Abstract]
Non-Controlling Interests	Note 3 : Non-Controlling Interests Semiconductor Co-Investment Program In 2022, we closed a transaction with Brookfield Asset Management (Brookfield) resulting in the formation of Arizona Fab LLC (Arizona Fab), a VIE for which we and Brookfield own 51% and 49%, respectively. Because we are the primary beneficiary of the VIE, we fully consolidate the results of Arizona Fab into our consolidated financial statements. Generally, contributions will be made to, and distributions will be received from, Arizona Fab based on both parties’ proportional ownership. We will be the sole operator and majority owner of two new chip factories that will be constructed by Arizona Fab, and we will have the right to purchase 100% of the related factory output. Once production commences, we will be required to operate Arizona Fab at minimum production levels measured in wafer starts per week and will be required to limit excess inventory held on site or we will be subject to certain penalties. We have an unrecognized commitment to fund our respective share of the total construction costs of Arizona Fab of $29.0 billion. As of April 1, 2023, a substantial majority of the assets of Arizona Fab consisted of property, plant and equipment. The assets held by Arizona Fab, which can be used only to settle obligations of the VIE and are not available to us, were $2.7 billion as of April 1, 2023 ($1.8 billion as of December 31, 2022). Non-controlling interest in Arizona Fab was $1.3 billion as of April 1, 2023 ($874 million as of December 31, 2022). Net loss attributable to non-controlling interest in Arizona Fab was $5 million in the first three months of 2023; there was no net income (loss) attributable to non-controlling interest in the first three months of 2022. Mobileye In October 2022, Mobileye completed its IPO and certain other equity financing transactions that resulted in net proceeds of $1.0 billion. As of April 1, 2023, Intel held approximately 94% (94% as of December 31, 2022) of the outstanding equity interest in Mobileye. Non-controlling interest in Mobileye was $1.0 billion as of April 1, 2023 ($1.0 billion as of December 31, 2022). Net loss attributable to non-controlling interest in Mobileye was $5 million in the first three months of 2023; there was no net income (loss) attributable to non-controlling interest in the first three months of 2022.

Earnings Per Share

Earnings Per Share	3 Months Ended
Earnings Per Share	Apr. 01, 2023
Earnings Per Share [Abstract]
Earnings Per Share	Note 4 : Earnings (Loss) Per Share We computed basic earnings (loss) per share of common stock based on the weighted average number of shares of common stock outstanding during the period. We computed diluted earnings (loss) per share of common stock based on the weighted average number of shares of common stock outstanding plus potentially dilutive shares of common stock outstanding during the period. Three Months Ended (In Millions, Except Per Share Amounts) Apr 1, 2023 Apr 2, 2022 Net income (loss) $ (2,768) $ 8,113 Less: Net income (loss) attributable to non-controlling interests (10) — Net income (loss) attributable to Intel (2,758) 8,113 Weighted average shares of common stock outstanding—basic 4,154 4,079 Dilutive effect of employee equity incentive plans — 28 Weighted average shares of common stock outstanding—diluted 4,154 4,107 Earnings (loss) per share attributable to Intel—basic $ (0.66) $ 1.99 Earnings (loss) per share attributable to Intel—diluted $ (0.66) $ 1.98 Potentially dilutive shares of common stock from employee equity incentive plans are determined by applying the treasury stock method to the assumed exercise of outstanding stock options, the assumed vesting of outstanding RSUs, and the assumed issuance of common stock under the stock purchase plan. Due to our net loss in the first three months of 2023, the assumed exercise of outstanding stock options, the assumed vesting of outstanding RSUs, and the assumed issuance of common stock under the stock purchase plan had an antidilutive effect on diluted earnings per share.

Other Financial Statement Detai

Other Financial Statement Details	3 Months Ended
Other Financial Statement Details	Apr. 01, 2023
Other Financial Statement Details [Abstract]
Other Financial Statement Details	Note 5 : Other Financial Statement Details Accounts Receivable We sell certain of our accounts receivable on a non-recourse basis to third-party financial institutions. We record these transactions as sales of receivables and present cash proceeds as cash provided by operating activities in the Consolidated Condensed Statements of Cash Flows. Accounts receivable sold under non-recourse factoring arrangements were $500 million during the first three months of 2023, and we did not factor accounts receivable during the first three months of 2022. After the sale of our accounts receivable, we will collect payment from the customers and remit it to the third-party financial institution. Inventories (In Millions) Apr 1, 2023 Dec 31, 2022 Raw materials $ 1,358 $ 1,517 Work in process 7,415 7,565 Finished goods 4,220 4,142 Total inventories $ 12,993 $ 13,224 Interest and Other, Net Three Months Ended (In Millions) Apr 1, 2023 Apr 2, 2022 Interest income $ 334 $ 47 Interest expense (193) (124) Other, net — 1,074 Total interest and other, net $ 141 $ 997 Interest expense is net of $363 million of interest capitalized in the first three months of 2023 ($142 million in the first three months of 2022). Other, net includes a gain in 2022 of $1.0 billion resulting from the first closing of the divestiture of our NAND memory business.

Restructuring and Other Charges

Restructuring and Other Charges	3 Months Ended
Restructuring and Other Charges	Apr. 01, 2023
Restructuring and Related Activities [Abstract]
Restructuring and Other Charges	Note 6 : Restructuring and Other Charges Three Months Ended (In Millions) Apr 1, 2023 Apr 2, 2022 Employee severance and benefit arrangements $ (39) $ 5 Litigation charges and other 77 (1,216) Asset impairment charges 26 — Total restructuring and other charges $ 64 $ (1,211) The 2022 Restructuring Program was approved in the third quarter of 2022 to rebalance our workforce and operations to create efficiencies and improve our product execution in alignment with our strategy. We expect these actions to be substantially completed by the end of 2023, but this is subject to change. Any changes to the estimates or timing of executing the 2022 Restructuring Program will be reflected in our results of operations. Restructuring activity for the 2022 Restructuring Program during the first three months of 2023 was as follows: (In Millions) Accrued restructuring balance as of December 31, 2022 $ 873 Adjustments (41) Cash payments (487) Accrued restructuring balance as of April 1, 2023 $ 345 The accrued restructuring balance as of April 1, 2023, was recorded as a current liability within accrued compensation and benefits on the Consolidated Condensed Balance Sheets . Litigation charges and other includes a $1.2 billion benefit in the first three months of 2022 from the annulled penalty related to an EC fine that was recorded and paid in 2009. Refer to "Note 12: Contingencies" within the Notes to Consolidated Condensed Financial Statements for further information on legal proceedings related to the EC fine.

Investments

Investments	3 Months Ended
Investments	Apr. 01, 2023
Investments, Debt and Equity Securities [Abstract]
Investments	Note 7 : Investments Short-term Investments Short-term investments include marketable debt investments in corporate debt, government debt, and financial institution instruments. Government debt includes instruments such as non-US government bonds and US agency securities. Financial institution instruments include instruments issued or managed by financial institutions in various forms, such as commercial paper, fixed- and floating-rate bonds, money market fund deposits, and time deposits. As of April 1, 2023, and December 31, 2022, substantially all time deposits were issued by institutions outside the US. For certain of our marketable debt investments, we economically hedge market risks at inception with a related derivative instrument or the marketable debt investment itself is used to economically hedge currency exchange rate risk from remeasurement. These hedged investments are reported at fair value with gains or losses from the investments and the related derivative instruments recorded in interest and other, net . The fair value of our hedged investments was $18.2 billion as of April 1, 2023 ($16.2 billion as of December 31, 2022). For hedged investments still held at the reporting date, we recorded net gains of $90 million in the first three months of 2023 ($411 million of net losses in the first three months of 2022). We recorded net losses on the related derivatives of $102 million in the first three months of 2023 ($377 million of net gains in the first three months of 2022). Our remaining unhedged marketable debt investments are reported at fair value, with unrealized gains or losses, net of tax, recorded in accumulated other comprehensive income (loss) . The adjusted cost of our unhedged investments was $7.0 billion as of April 1, 2023 ($10.2 billion as of December 31, 2022), which approximated the fair value for these periods. The fair value of marketable debt investments, by contractual maturity, as of April 1, 2023, was as follows: (In Millions) Fair Value Due in 1 year or less $ 15,874 Due in 1–2 years 1,805 Due in 2–5 years 4,850 Due after 5 years 734 Instruments not due at a single maturity date 1 1,947 Total $ 25,210 1 Instruments not due at a single maturity date is comprised of money market fund deposits, which are classified as either short-term investments or cash and cash equivalents. Equity Investments (In Millions) Apr 1, 2023 Dec 31, 2022 Marketable equity securities 1 $ 1,421 $ 1,341 Non-marketable equity securities 4,598 4,561 Equity method investments 10 10 Total $ 6,029 $ 5,912 1 Over 90% of our marketable equity securities are subject to trading-volume or market-based restrictions, which limit the number of shares we may sell in a specified period of time, impacting our ability to liquidate these investments. The trading volume restrictions generally apply for as long as we own more than 1% of the outstanding shares. Market-based restrictions result from the rules of the respective exchange. The components of gains (losses) on equity investments, net for each period were as follows: Three Months Ended (In Millions) Apr 1, 2023 Apr 2, 2022 Ongoing mark-to-market adjustments on marketable equity securities $ 188 $ (430) Observable price adjustments on non-marketable equity securities 10 71 Impairment charges (36) (23) Sale of equity investments and other 1 7 4,705 Total gains (losses) on equity investments, net $ 169 $ 4,323 1 Sale of equity investments and other includes initial fair value adjustments recorded upon a security becoming marketable, realized gains (losses) on sales of non-marketable equity investments and equity method investments, and our share of equity method investee gains (losses) and distributions. Net unrealized gains and losses for our marketable and non-marketable equity securities for each period were as follows: Three Months Ended (In Millions) Apr 1, 2023 Apr 2, 2022 Net unrealized gains (losses) recognized during the period on equity securities $ 166 $ (244) Less: Net (gains) losses recognized during the period on equity securities sold during the period (3) (17) Net unrealized gains (losses) recognized during the reporting period on equity securities still held at the reporting date $ 163 $ (261) McAfee Corp.

Acquisitions and Divestitures

Acquisitions and Divestitures	3 Months Ended
Acquisitions and Divestitures	Apr. 01, 2023
Business Combinations [Abstract]
Acquisitions and Divestitures	Note 8 : Acquisitions and Divestitures Acquisitions Acquisition of Tower Semiconductor During the first quarter of 2022 , we entered into a definitive agreement to acquire Tower Semiconductor Ltd. (Tower) in a cash-for-stock transaction. Tower is a leading foundry for analog semiconductor solutions. The acquisition is expected to advance our IDM 2.0 strategy by accelerating our global end-to-end foundry business. Upon completion of the acquisition, each issued and outstanding ordinary share of Tower will be converted into the right to receive $53 per share in cash, representing a total enterprise value of approximately $5.4 billion as of the agreement date. We continue to work to close the transaction, which is subject to certain regulatory approvals and customary closing conditions. If regulatory approvals are not received prior to August 15, 2023, and the agreement is terminated by either party, we may be obligated to pay Tower a termination fee of $353 million. Tower will be included in our IFS operating segment. Divestitures NAND Memory Business On December 29, 2021, we closed the first phase of our agreement with SK hynix Inc. (SK hynix) to divest our NAND memory business for $9.0 billion in cash. Our NAND memory business includes our NAND memory technology and manufacturing business (the NAND OpCo Business), of which we deconsolidated our ongoing interests in as part of the sale . The transaction will be completed in two closings and upon first closing in the first three months 2022, SK hynix paid $7.0 billion of consideration and we recognized a pre-tax gain of $1.0 billion within interest and other, net , and tax expense of $495 million. We recorded a receivable in other long-term assets for the remaining proceeds of $1.9 billion which remains outstanding as of April 1, 2023, and will be received upon the second closing of the transaction, expected to be no earlier than March 2025. The wafer manufacturing and sale agreement includes incentives and penalties that are contingent on the cost of operation and output of the NAND OpCo Business. These incentives and penalties present a maximum exposure of up to $500 million annually, and $1.5 billion in the aggregate. We are currently in negotiations with SK hynix to update the operating plan of the NAND OpCo Business in light of the current business environment and projections, which may impact the metrics associated with the incentives and penalties and our expectations of the performance of the NAND OpCo Business against those metrics. As of April 1, 2023, we also have a receivable due from the NAND OpCo Business, a deconsolidated entity, of $184 million recorded within other current assets

Borrowings

Borrowings	3 Months Ended
Borrowings	Apr. 01, 2023
Debt Disclosure [Abstract]
Borrowings	Note 9 : Borrowings In the first quarter of 2023, we issued a total of $11.0 billion aggregate principal amount of senior notes. We also amended both our 5-year $5.0 billion revolving credit facility agreement, extending the maturity date by one year to March 2028, and our 364-day credit facility agreement, extending the maturity date to March 2024. The revolving credit facilities had no borrowings outstanding as of April 1, 2023. We have an ongoing authorization from our Board of Directors to borrow up to $10.0 billion under our commercial paper program. In the first quarter of 2023, we settled in cash $2.9 billion of our commercial paper and had $1.0 billion outstanding as of April 1, 2023. Our senior fixed rate notes pay interest semiannually. We may redeem the fixed rate notes prior to their maturity at our option at specified redemption prices and subject to certain restrictions. The obligations under our senior fixed rate notes rank equally in the right of payment with all of our other existing and future senior unsecured indebtedness and effectively rank junior to all liabilities of our subsidiaries.

Fair Value

Fair Value	3 Months Ended
Fair Value	Apr. 01, 2023
Fair Value Disclosures [Abstract]
Fair Value	Note 10 : Fair Value Assets and Liabilities Measured and Recorded at Fair Value on a Recurring Basis Apr 1, 2023 Dec 31, 2022 Fair Value Measured and Recorded at Reporting Date Using Fair Value Measured and Recorded at Reporting Date Using (In Millions) Level 1 Level 2 Level 3 Total Level 1 Level 2 Level 3 Total Assets Cash equivalents: Corporate debt $ — $ 1,395 $ — $ 1,395 $ — $ 856 $ — $ 856 Financial institution instruments¹ 1,806 2,177 — 3,983 6,899 1,474 — 8,373 Government debt² 233 297 — 530 — — — — Reverse repurchase agreements — 1,700 — 1,700 — 1,301 — 1,301 Short-term investments: Corporate debt — 5,441 — 5,441 — 5,381 — 5,381 Financial institution instruments¹ 141 5,019 — 5,160 196 4,729 — 4,925 Government debt² 49 8,652 — 8,701 48 6,840 — 6,888 Other current assets: Derivative assets 78 959 — 1,037 — 1,264 — 1,264 Loans receivable³ — 54 — 54 — 53 — 53 Marketable equity securities 1,421 — — 1,421 1,341 — — 1,341 Other long-term assets: Derivative assets — 5 — 5 — 10 — 10 Total assets measured and recorded at fair value $ 3,728 $ 25,699 $ — $ 29,427 $ 8,484 $ 21,908 $ — $ 30,392 Liabilities Other accrued liabilities: Derivative liabilities $ 8 $ 350 $ 81 $ 439 $ 111 $ 485 $ 89 $ 685 Other long-term liabilities: Derivative liabilities — 515 — 515 — 699 — 699 Total liabilities measured and recorded at fair value $ 8 $ 865 $ 81 $ 954 $ 111 $ 1,184 $ 89 $ 1,384 1 Level 1 investments consist of money market funds. Level 2 investments consist primarily of commercial paper, certificates of deposit, time deposits, and notes and bonds issued by financial institutions. 2 Level 1 investments consist primarily of US Treasury securities. Level 2 investments consist primarily of non-US government debt. 3 The fair value of our loans receivable for which we elected the fair value option did not significantly differ from the contractual principal balance. Assets Measured and Recorded at Fair Value on a Non-Recurring Basis Our non-marketable equity securities, equity method investments, and certain non-financial assets, such as intangible assets and property, plant and equipment, are recorded at fair value only if an impairment or observable price adjustment is recognized in the current period. If an observable price adjustment or impairment is recognized on our non-marketable equity securities during the period, we classify these assets as Level 3. Financial Instruments Not Recorded at Fair Value on a Recurring Basis Financial instruments not recorded at fair value on a recurring basis include non-marketable equity securities and equity method investments that have not been remeasured or impaired in the current period, grants receivable, reverse repurchase agreements with original maturities greater than three months, and issued debt.

Other Comprehensive Income (Los

Other Comprehensive Income (Loss)	3 Months Ended
Other Comprehensive Income (Loss)	Apr. 01, 2023
Equity [Abstract]
Other Comprehensive Income (Loss)	Note : Other Comprehensive Income (Loss) The changes in accumulated other comprehensive income (loss) by component and related tax effects in the first three months of 2023 were as follows: (In Millions) Unrealized Holding Gains (Losses) on Derivatives Actuarial Valuation and Other Pension Expenses Translation Adjustments and Other Total Balance as of December 31, 2022 $ (299) $ (259) $ (4) $ (562) Other comprehensive income (loss) before reclassifications 53 — — 53 Amounts reclassified out of accumulated other comprehensive income (loss) 141 1 — 142 Tax effects (52) — — (52) Other comprehensive income (loss) 142 1 — 143 Balance as of April 1, 2023 $ (157) $ (258) $ (4) $ (419) We estimate that we will reclassify approximately $97 million (before taxes) of net derivative losses from accumulated other comprehensive income (loss)

Derivative Financial Instrument

Derivative Financial Instruments	3 Months Ended
Derivative Financial Instruments	Apr. 01, 2023
Derivative Instruments and Hedging Activities Disclosure [Abstract]
Derivative Financial Instruments	Note 11 : Derivative Financial Instruments Volume of Derivative Activity Total gross notional amounts for outstanding derivatives (recorded at fair value) at the end of each period were as follows: (In Millions) Apr 1, 2023 Dec 31, 2022 Foreign currency contracts $ 30,847 $ 31,603 Interest rate contracts 16,590 16,011 Other 2,058 2,094 Total $ 49,495 $ 49,708 Fair Value of Derivative Instruments in the Consolidated Condensed Balance Sheets Apr 1, 2023 Dec 31, 2022 (In Millions) Assets 1 Liabilities 2 Assets 1 Liabilities 2 Derivatives designated as hedging instruments: Foreign currency contracts 3 $ 187 $ 185 $ 142 $ 290 Interest rate contracts — 585 — 777 Total derivatives designated as hedging instruments 187 770 142 1,067 Derivatives not designated as hedging instruments: Foreign currency contracts 3 537 156 866 194 Interest rate contracts 240 20 266 12 Equity contracts 78 8 — 111 Total derivatives not designated as hedging instruments 855 184 1,132 317 Total derivatives $ 1,042 $ 954 $ 1,274 $ 1,384 1 Derivative assets are recorded as other assets, current and long-term. 2 Derivative liabilities are recorded as other liabilities, current and long-term. 3 The substantial majority of these instruments mature within 12 months. Amounts Offset in the Consolidated Condensed Balance Sheets Agreements subject to master netting arrangements with various counterparties, and cash and non-cash collateral posted under such agreements at the end of each period were as follows: Apr 1, 2023 Gross Amounts Not Offset in the Balance Sheet (In Millions) Gross Amounts Recognized Gross Amounts Offset in the Balance Sheet Net Amounts Presented in the Balance Sheet Financial Instruments Cash and Non-Cash Collateral Received or Pledged Net Amount Assets: Derivative assets subject to master netting arrangements $ 966 $ — $ 966 $ (471) $ (495) $ — Reverse repurchase agreements 1,700 — 1,700 — (1,700) — Total assets 2,666 — 2,666 (471) (2,195) — Liabilities: Derivative liabilities subject to master netting arrangements 935 — 935 (471) (392) 72 Total liabilities $ 935 $ — $ 935 $ (471) $ (392) $ 72 Dec 31, 2022 Gross Amounts Not Offset in the Balance Sheet (In Millions) Gross Amounts Recognized Gross Amounts Offset in the Balance Sheet Net Amounts Presented in the Balance Sheet Financial Instruments Cash and Non-Cash Collateral Received or Pledged Net Amount Assets: Derivative assets subject to master netting arrangements $ 1,231 $ — $ 1,231 $ (546) $ (682) $ 3 Reverse repurchase agreements 1,701 — 1,701 — (1,701) — Total assets 2,932 — 2,932 (546) (2,383) 3 Liabilities: Derivative liabilities subject to master netting arrangements 1,337 — 1,337 (546) (712) 79 Total liabilities $ 1,337 $ — $ 1,337 $ (546) $ (712) $ 79 We obtain and secure available collateral from counterparties against obligations, including securities lending transactions and reverse repurchase agreements, when we deem it appropriate. Derivatives in Cash Flow Hedging Relationships The before-tax net gains or losses attributed to cash flow hedges recognized in other comprehensive income (loss) were $53 million net gains in the first three months of 2023 ($115 million net losses in the first three months of 2022). Substantially all of our cash flow hedges were foreign currency contracts for all periods presented. During the first three months of 2023 and 2022, the amounts excluded from effectiveness testing were insignificant. Derivatives in Fair Value Hedging Relationships The effects of derivative instruments designated as fair value hedges, recognized in interest and other, net for each period were as follows: Gains (Losses) Recognized in Consolidated Condensed Statements of Income on Derivatives Three Months Ended (In Millions) Apr 1, 2023 Apr 2, 2022 Interest rate contracts $ 192 $ (711) Hedged items (192) 711 Total $ — $ — The amounts recorded on the Consolidated Condensed Balance Sheets related to cumulative basis adjustments for fair value hedges for each period were as follows: Line Item in the Consolidated Condensed Balance Sheets in Which the Hedged Item is Included Carrying Amount of the Hedged Item Asset/(Liabilities) Cumulative Amount of Fair Value Hedging Adjustment Included in the Carrying Amount Assets/(Liabilities) (In Millions) Apr 1, 2023 Dec 31, 2022 Apr 1, 2023 Dec 31, 2022 Long-term debt $ (11,413) $ (11,221) $ 584 $ 776 The total notional amount of pay-variable and receive-fixed interest rate swaps was $12.0 billion as of April 1, 2023 and $12.0 billion as of December 31, 2022. Derivatives Not Designated as Hedging Instruments The effects of derivative instruments not designated as hedging instruments on the Consolidated Condensed Statements of Income for each period were as follows: Three Months Ended (In Millions) Location of Gains (Losses) Apr 1, 2023 Apr 2, 2022 Foreign currency contracts Interest and other, net $ 1 $ 158 Interest rate contracts Interest and other, net (34) 94 Other Various 115 (134) Total $ 82 $ 118

Contingencies

Contingencies	3 Months Ended
Contingencies	Apr. 01, 2023
Commitments and Contingencies Disclosure [Abstract]
Contingencies	Note 12 : Contingencies Legal Proceedings We are regularly party to various ongoing claims, litigation, and other proceedings, including those noted in this section. We have accrued a charge of $2.2 billion related to litigation involving VLSI, described below. Excluding the VLSI claims described below, management at present believes that the ultimate outcome of these proceedings, individually and in the aggregate, will not materially harm our financial position, results of operations, cash flows, or overall trends; however, legal proceedings and related government investigations are subject to inherent uncertainties, and unfavorable rulings, excessive verdicts, or other events could occur. Unfavorable resolutions could include substantial monetary damages, fines, or penalties. Certain of these outstanding matters include speculative, substantial, or indeterminate monetary awards. In addition, in matters for which injunctive relief or other conduct remedies are sought, unfavorable resolutions could include an injunction or other order prohibiting us from selling one or more products at all or in particular ways, precluding particular business practices, or requiring other remedies. An unfavorable outcome may result in a material adverse impact on our business, results of operations, financial position, and overall trends. We might also conclude that settling one or more such matters is in the best interests of our stockholders, employees, and customers, and any such settlement could include substantial payments. Except as specifically described below, we have not concluded that settlement of any of the legal proceedings noted in this section is appropriate at this time. European Commission Competition Matter I n 2009, the European Commission (EC) found that Intel had used unfair business practices to persuade customers to buy microprocessors in violation of Article 82 of the EC Treaty (later renumbered Article 102) and Article 54 of the European Economic Area Agreement. In general, the EC found that we violated Article 82 by offering alleged “conditional rebates and payments” that required customers to purchase all or most of their x86 microprocessors from us and by making alleged “payments to prevent sales of specific rival products.” The EC ordered us to end the alleged infringement referred to in its decision and imposed a €1.1 billion fine, which we paid in the third quarter of 2009. We appealed the EC decision to the European Court of Justice in 2014, after the General Court (then called the Court of First Instance) rejected our appeal of the EC decision in its entirety. In September 2017, the Court of Justice sent the case back to the General Court to examine whether the rebates at issue were capable of restricting competition. In January 2022, the General Court annulled the EC’s 2009 findings against Intel regarding rebates, as well as the fine imposed on Intel, which was returned to us in February 2022. In April 2022, the EC appealed the General Court’s decision to the Court of Justice. A hearing date on the appeal has not been scheduled. The General Court’s January 2022 decision did not annul the EC’s 2009 finding that Intel made payments to prevent sales of specific rival products, and in January 2023 the EC reopened its administrative procedure to determine a fine against Intel based on that alleged conduct. Given the procedural posture and the nature of this proceeding, we are unable to make a reasonable estimate of the potential loss or range of losses, if any, that might arise from this matter. In a related matter, in April 2022 we filed applications with the General Court seeking an order requiring the EC to pay Intel approximately €593 million in default interest, which applications have been stayed pending the EC’s appeal of the General Court’s January 2022 decisio n . Litigation Related to Security Vulnerabilities In June 2017, a Google research team notified Intel and other companies that it had identified security vulnerabilities, now commonly referred to as “Spectre” and “Meltdown,” that affect many types of microprocessors, including our products. As is standard when findings like these are presented, we worked together with other companies in the industry to verify the research and develop and validate software and firmware updates for impacted technologies. In January 2018, information on the security vulnerabilities was publicly reported before software and firmware updates to address the vulnerabilities were made widely available. Numerous lawsuits have been filed against Intel relating to Spectre, Meltdown, and other variants of the security vulnerabilities that have been identified since 2018. As of January 25, 2023, consumer class action lawsuits against Intel were pending in the United States, Canada, and Argentina. The plaintiffs, who purport to represent various classes of purchasers of our products, generally claim to have been harmed by Intel's actions and/or omissions in connection with the security vulnerabilities and assert a variety of common law and statutory claims seeking monetary damages and equitable relief. In the United States, class action suits filed in various jurisdictions were consolidated for all pretrial proceedings in the US District Court for the District of Oregon, which entered final judgment in favor of Intel in July 2022 based on plaintiffs’ failure to plead a viable claim. Plaintiffs have appealed that decision to the Ninth Circuit Court of Appeals. In Canada, an initial status conference has not yet been scheduled in one case pending in the Superior Court of Justice of Ontario, and a stay of a second case pending in the Superior Court of Justice of Quebec is in effect. In Argentina, Intel Argentina was served with, and responded to, a class action complaint in June 2022. Additional lawsuits and claims may be asserted seeking monetary damages or other related relief. We dispute the pending claims described above and intend to defend those lawsuits vigorously. Given the procedural posture and the nature of those cases, including that the pending proceedings are in the early stages, that alleged damages have not been specified, that uncertainty exists as to the likelihood of a class or classes being certified or the ultimate size of any class or classes if certified, and that there are significant factual and legal issues to be resolved, we are unable to make a reasonable estimate of the potential loss or range of losses, if any, that might arise from those matters. Litigation Related to 7nm Product Delay Announcement Multiple securities class action lawsuits were filed in the US District Court for the Northern District of California against Intel and certain officers following Intel’s July 2020 announcement of 7nm product delays. The court consolidated the lawsuits and appointed lead plaintiffs in October 2020, and in January 2021 plaintiffs filed a consolidated complaint. Plaintiffs purport to represent all persons who purchased or otherwise acquired Intel common stock from October 25, 2019 through October 23, 2020, and they generally allege that defendants violated the federal securities laws by making false or misleading statements about the timeline for 7nm products. In March 2023, the court granted defendants’ motion to dismiss the consolidated complaint, with leave to amend. Given the procedural posture and the nature of the case, including that it is in the early stages, that alleged damages have not been specified, that uncertainty exists as to the likelihood of a class being certified or the ultimate size of any class if certified, and that there are significant factual and legal issues to be resolved, we are unable to make a reasonable estimate of the potential loss or range of losses, if any, that might arise from the matter. In July 2021, Intel introduced a new process node naming structure, and the 7nm process is now called Intel 4. Litigation Related to Patent and IP Claims We have had IP infringement lawsuits filed against us, including but not limited to those discussed below. Most involve claims that certain of our products, services, and technologies infringe others' IP rights. Adverse results in these lawsuits may include awards of substantial fines and penalties, costly royalty or licensing agreements, or orders preventing us from offering certain features, functionalities, products, or services. As a result, we may have to change our business practices, and develop non-infringing products or technologies, which could result in a loss of revenue for us and otherwise harm our business. In addition, certain agreements with our customers require us to indemnify them against certain IP infringement claims, which can increase our costs as a result of defending such claims, and may require that we pay significant damages, accept product returns, or supply our customers with non-infringing products if there were an adverse ruling in any such claims. In addition, our customers and partners may discontinue the use of our products, services, and technologies, as a result of injunctions or otherwise, which could result in loss of revenue and adversely affect our business. VLSI Technology LLC v. Intel In October 2017, VLSI Technology LLC (VLSI) filed a complaint against Intel in the US District Court for the Northern District of California alleging that various Intel FPGA and processor products infringe eight patents that VLSI acquired from NXP Semiconductors, N.V. (NXP). Four patents remain at issue in the case, and VLSI estimates its damages to be approximately $900 million, and seeks enhanced damages, future royalties, attorneys’ fees, costs, and interest. Intel filed Inter Partes Review (IPR) petitions with the Patent Trial and Appeal Board (PTAB) in 2018 challenging patentability, and the parties stipulated to stay the district court action pending the PTAB's review. The PTAB subsequently found all claims of two patents, and some claims of two other patents, to be unpatentable. The district court lifted the stay in September 2021 and scheduled trial for March 2024 on the claims that were found patentable by the PTAB. In June 2018, VLSI filed a second suit against Intel, in US District Court for the District of Delaware, seeking $4.4 billion in damages for the alleged infringement by various Intel processors of five additional patents that VLSI acquired from NXP. In December 2022, VLSI stipulated to dismiss with prejudice its claims, for which Intel paid nothing. The court dismissed the case in January 2023. In April 2019, VLSI filed three infringement suits against Intel in the US District Court for the Western District of Texas accusing various Intel processors of infringement of eight additional patents it had acquired from NXP. The first Texas case went to trial in February 2021, and the jury awarded VLSI $1.5 billion for literal infringement of one patent and $675 million for infringement of another patent under the doctrine of equivalents. In April 2022, the court entered final judgment, awarding VLSI $2.2 billion in damages and approximately $162.3 million in pre-judgment and post-judgment interest. Intel has appealed the judgment to the Federal Circuit Court of Appeals, including its claim to have a license from Fortress Investment Group’s acquisition of Finjan. In December 2021 and January 2022, the PTAB instituted IPRs on the claims found to have been infringed in the first Texas case, but it has not yet issued a final written decision on either petition. The second Texas case went to trial in April 2021, and the jury found that Intel does not infringe the asserted patents. VLSI had sought approximately $3.0 billion for alleged infringement, plus enhanced damages for willful infringement. The court has not yet entered final judgment following the second trial in Texas. The third Texas case went to trial in November 2022, with VLSI asserting one remaining patent. The jury found the patent valid and infringed, and awarded VLSI approximately $949 million in damages, plus a running royalty. The court has not yet entered final judgment following the third trial in Texas. In February 2023, Intel filed motions for a new trial and for judgment as a matter of law notwithstanding the verdict on various grounds. Further appeals are possible. In May 2019, VLSI filed a case in Shenzhen Intermediate People’s Court against Intel, Intel (China) Co., Ltd., Intel Trading (Shanghai) Co., Ltd., and Intel Products (Chengdu) Co., Ltd. VLSI asserts one patent against certain Intel Core processors. Defendants filed an invalidation petition in October 2019 with the China National Intellectual Property Administration (CNIPA), which held a hearing in September 2021. CNIPA has not yet issued a decision. The Shenzhen court held trial proceedings in July 2021 and stated that further trial proceedings were needed but would be stayed pending the outcome of defendants’ invalidity challenge at the CNIPA. VLSI seeks an injunction as well as RMB 1.3 million in costs and expenses, but no damages. In May 2019, VLSI filed a case in Shanghai Intellectual Property Court against Intel (China) Co., Ltd., Intel Trading (Shanghai) Co., Ltd., and Intel Products (Chengdu) Co., Ltd. asserting one patent against certain Intel core processors. The court held a trial hearing in December 2020, where VLSI requested expenses (RMB 300 thousand) and an injunction. The court held a second trial hearing in May 2022, but has yet to issue its final decision. In December 2022, Intel filed a second petition to invalidate the patent at issue. Intel has accrued a charge of approximately $2.2 billion related to the VLSI litigation. While we dispute VLSI’s claims and intend to vigorously defend against them, we are unable to make a reasonable estimate of losses in excess of recorded amounts given recent developments and future proceedings.

Operating Segments (Tables)

Operating Segments (Tables)	3 Months Ended
Operating Segments (Tables)	Apr. 01, 2023
Segment Reporting [Abstract]
Schedule of Segment Reporting Information, by Segment [Table Text Block]	Net revenue and operating income (loss) for each period were as follows: Three Months Ended (In Millions) Apr 1, 2023 Apr 2, 2022 Net revenue: Client Computing Desktop $ 1,879 $ 2,641 Notebook 3,407 5,959 Other 481 722 5,767 9,322 Data Center and AI 3,718 6,074 Network and Edge 1,489 2,139 Mobileye 458 394 Intel Foundry Services 118 156 All other 165 268 Total net revenue $ 11,715 $ 18,353 Operating income (loss): Client Computing $ 520 $ 2,722 Data Center and AI (518) 1,393 Network and Edge (300) 416 Mobileye 123 148 Intel Foundry Services (140) (23) All other (1,153) (315) Total operating income (loss) $ (1,468) $ 4,341

Earnings Per Share (Tables)

Earnings Per Share (Tables)	3 Months Ended
Earnings Per Share (Tables)	Apr. 01, 2023
Earnings Per Share [Abstract]
Schedule of Earnings Per Share, Basic and Diluted [Table Text Block]	Three Months Ended (In Millions, Except Per Share Amounts) Apr 1, 2023 Apr 2, 2022 Net income (loss) $ (2,768) $ 8,113 Less: Net income (loss) attributable to non-controlling interests (10) — Net income (loss) attributable to Intel (2,758) 8,113 Weighted average shares of common stock outstanding—basic 4,154 4,079 Dilutive effect of employee equity incentive plans — 28 Weighted average shares of common stock outstanding—diluted 4,154 4,107 Earnings (loss) per share attributable to Intel—basic $ (0.66) $ 1.99 Earnings (loss) per share attributable to Intel—diluted $ (0.66) $ 1.98

Other Financial Statement Det_2

Other Financial Statement Details (Tables)	3 Months Ended
Other Financial Statement Details (Tables)	Apr. 01, 2023
Other Financial Statement Details [Abstract]
Schedule of Inventory, Current [Table Text Block]	(In Millions) Apr 1, 2023 Dec 31, 2022 Raw materials $ 1,358 $ 1,517 Work in process 7,415 7,565 Finished goods 4,220 4,142 Total inventories $ 12,993 $ 13,224
Interest and Other, Net [Table Text Block]	Three Months Ended (In Millions) Apr 1, 2023 Apr 2, 2022 Interest income $ 334 $ 47 Interest expense (193) (124) Other, net — 1,074 Total interest and other, net $ 141 $ 997

Restructuring and Other Charg_2

Restructuring and Other Charges (Tables)	3 Months Ended
Restructuring and Other Charges (Tables)	Apr. 01, 2023
Restructuring and Related Activities [Abstract]
Schedule of Restructuring and Other Charges	Three Months Ended (In Millions) Apr 1, 2023 Apr 2, 2022 Employee severance and benefit arrangements $ (39) $ 5 Litigation charges and other 77 (1,216) Asset impairment charges 26 — Total restructuring and other charges $ 64 $ (1,211)
Schedule of Accrued Restructuring	Restructuring activity for the 2022 Restructuring Program during the first three months of 2023 was as follows: (In Millions) Accrued restructuring balance as of December 31, 2022 $ 873 Adjustments (41) Cash payments (487) Accrued restructuring balance as of April 1, 2023 $ 345

Investments (Tables)

Investments (Tables)	3 Months Ended
Investments (Tables)	Apr. 01, 2023
Investments, Debt and Equity Securities [Abstract]
Investments Classified by Contractual Maturity Date [Table Text Block]	The fair value of marketable debt investments, by contractual maturity, as of April 1, 2023, was as follows: (In Millions) Fair Value Due in 1 year or less $ 15,874 Due in 1–2 years 1,805 Due in 2–5 years 4,850 Due after 5 years 734 Instruments not due at a single maturity date 1 1,947 Total $ 25,210
Investment [Table Text Block]	(In Millions) Apr 1, 2023 Dec 31, 2022 Marketable equity securities 1 $ 1,421 $ 1,341 Non-marketable equity securities 4,598 4,561 Equity method investments 10 10 Total $ 6,029 $ 5,912 1 Over 90% of our marketable equity securities are subject to trading-volume or market-based restrictions, which limit the number of shares we may sell in a specified period of time, impacting our ability to liquidate these investments. The trading volume restrictions generally apply for as long as we own more than 1% of the outstanding shares. Market-based restrictions result from the rules of the respective exchange.
Gain (Loss) on Securities [Table Text Block]	The components of gains (losses) on equity investments, net for each period were as follows: Three Months Ended (In Millions) Apr 1, 2023 Apr 2, 2022 Ongoing mark-to-market adjustments on marketable equity securities $ 188 $ (430) Observable price adjustments on non-marketable equity securities 10 71 Impairment charges (36) (23) Sale of equity investments and other 1 7 4,705 Total gains (losses) on equity investments, net $ 169 $ 4,323 1 Sale of equity investments and other includes initial fair value adjustments recorded upon a security becoming marketable, realized gains (losses) on sales of non-marketable equity investments and equity method investments, and our share of equity method investee gains (losses) and distributions. Three Months Ended (In Millions) Apr 1, 2023 Apr 2, 2022 Net unrealized gains (losses) recognized during the period on equity securities $ 166 $ (244) Less: Net (gains) losses recognized during the period on equity securities sold during the period (3) (17) Net unrealized gains (losses) recognized during the reporting period on equity securities still held at the reporting date $ 163 $ (261)

Fair Value (Tables)

Fair Value (Tables)	3 Months Ended
Fair Value (Tables)	Apr. 01, 2023
Fair Value Disclosures [Abstract]
Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis [Table Text Block]	Assets and Liabilities Measured and Recorded at Fair Value on a Recurring Basis Apr 1, 2023 Dec 31, 2022 Fair Value Measured and Recorded at Reporting Date Using Fair Value Measured and Recorded at Reporting Date Using (In Millions) Level 1 Level 2 Level 3 Total Level 1 Level 2 Level 3 Total Assets Cash equivalents: Corporate debt $ — $ 1,395 $ — $ 1,395 $ — $ 856 $ — $ 856 Financial institution instruments¹ 1,806 2,177 — 3,983 6,899 1,474 — 8,373 Government debt² 233 297 — 530 — — — — Reverse repurchase agreements — 1,700 — 1,700 — 1,301 — 1,301 Short-term investments: Corporate debt — 5,441 — 5,441 — 5,381 — 5,381 Financial institution instruments¹ 141 5,019 — 5,160 196 4,729 — 4,925 Government debt² 49 8,652 — 8,701 48 6,840 — 6,888 Other current assets: Derivative assets 78 959 — 1,037 — 1,264 — 1,264 Loans receivable³ — 54 — 54 — 53 — 53 Marketable equity securities 1,421 — — 1,421 1,341 — — 1,341 Other long-term assets: Derivative assets — 5 — 5 — 10 — 10 Total assets measured and recorded at fair value $ 3,728 $ 25,699 $ — $ 29,427 $ 8,484 $ 21,908 $ — $ 30,392 Liabilities Other accrued liabilities: Derivative liabilities $ 8 $ 350 $ 81 $ 439 $ 111 $ 485 $ 89 $ 685 Other long-term liabilities: Derivative liabilities — 515 — 515 — 699 — 699 Total liabilities measured and recorded at fair value $ 8 $ 865 $ 81 $ 954 $ 111 $ 1,184 $ 89 $ 1,384 1 Level 1 investments consist of money market funds. Level 2 investments consist primarily of commercial paper, certificates of deposit, time deposits, and notes and bonds issued by financial institutions. 2 Level 1 investments consist primarily of US Treasury securities. Level 2 investments consist primarily of non-US government debt. 3 The fair value of our loans receivable for which we elected the fair value option did not significantly differ from the contractual principal balance.

Other Comprehensive Income (L_2

Other Comprehensive Income (Loss) (Tables)	3 Months Ended
Other Comprehensive Income (Loss) (Tables)	Apr. 01, 2023
Equity [Abstract]
Schedule of Accumulated Other Comprehensive Income (Loss) [Table Text Block]	The changes in accumulated other comprehensive income (loss) by component and related tax effects in the first three months of 2023 were as follows: (In Millions) Unrealized Holding Gains (Losses) on Derivatives Actuarial Valuation and Other Pension Expenses Translation Adjustments and Other Total Balance as of December 31, 2022 $ (299) $ (259) $ (4) $ (562) Other comprehensive income (loss) before reclassifications 53 — — 53 Amounts reclassified out of accumulated other comprehensive income (loss) 141 1 — 142 Tax effects (52) — — (52) Other comprehensive income (loss) 142 1 — 143 Balance as of April 1, 2023 $ (157) $ (258) $ (4) $ (419)

Derivative Financial Instrume_2

Derivative Financial Instruments (Tables)	3 Months Ended
Derivative Financial Instruments (Tables)	Apr. 01, 2023
Derivative [Line Items]
Schedule of Notional Amounts of Outstanding Derivative Positions [Table Text Block]	Total gross notional amounts for outstanding derivatives (recorded at fair value) at the end of each period were as follows: (In Millions) Apr 1, 2023 Dec 31, 2022 Foreign currency contracts $ 30,847 $ 31,603 Interest rate contracts 16,590 16,011 Other 2,058 2,094 Total $ 49,495 $ 49,708
Schedule of Derivative Instruments in Statement of Financial Position, Fair Value [Table Text Block]	Fair Value of Derivative Instruments in the Consolidated Condensed Balance Sheets Apr 1, 2023 Dec 31, 2022 (In Millions) Assets 1 Liabilities 2 Assets 1 Liabilities 2 Derivatives designated as hedging instruments: Foreign currency contracts 3 $ 187 $ 185 $ 142 $ 290 Interest rate contracts — 585 — 777 Total derivatives designated as hedging instruments 187 770 142 1,067 Derivatives not designated as hedging instruments: Foreign currency contracts 3 537 156 866 194 Interest rate contracts 240 20 266 12 Equity contracts 78 8 — 111 Total derivatives not designated as hedging instruments 855 184 1,132 317 Total derivatives $ 1,042 $ 954 $ 1,274 $ 1,384 1 Derivative assets are recorded as other assets, current and long-term. 2 Derivative liabilities are recorded as other liabilities, current and long-term. 3 The substantial majority of these instruments mature within 12 months. The amounts recorded on the Consolidated Condensed Balance Sheets related to cumulative basis adjustments for fair value hedges for each period were as follows: Line Item in the Consolidated Condensed Balance Sheets in Which the Hedged Item is Included Carrying Amount of the Hedged Item Asset/(Liabilities) Cumulative Amount of Fair Value Hedging Adjustment Included in the Carrying Amount Assets/(Liabilities) (In Millions) Apr 1, 2023 Dec 31, 2022 Apr 1, 2023 Dec 31, 2022 Long-term debt $ (11,413) $ (11,221) $ 584 $ 776
Offsetting Assets [Table Text Block]	Agreements subject to master netting arrangements with various counterparties, and cash and non-cash collateral posted under such agreements at the end of each period were as follows: Apr 1, 2023 Gross Amounts Not Offset in the Balance Sheet (In Millions) Gross Amounts Recognized Gross Amounts Offset in the Balance Sheet Net Amounts Presented in the Balance Sheet Financial Instruments Cash and Non-Cash Collateral Received or Pledged Net Amount Assets: Derivative assets subject to master netting arrangements $ 966 $ — $ 966 $ (471) $ (495) $ — Reverse repurchase agreements 1,700 — 1,700 — (1,700) — Total assets 2,666 — 2,666 (471) (2,195) — Liabilities: Derivative liabilities subject to master netting arrangements 935 — 935 (471) (392) 72 Total liabilities $ 935 $ — $ 935 $ (471) $ (392) $ 72 Dec 31, 2022 Gross Amounts Not Offset in the Balance Sheet (In Millions) Gross Amounts Recognized Gross Amounts Offset in the Balance Sheet Net Amounts Presented in the Balance Sheet Financial Instruments Cash and Non-Cash Collateral Received or Pledged Net Amount Assets: Derivative assets subject to master netting arrangements $ 1,231 $ — $ 1,231 $ (546) $ (682) $ 3 Reverse repurchase agreements 1,701 — 1,701 — (1,701) — Total assets 2,932 — 2,932 (546) (2,383) 3 Liabilities: Derivative liabilities subject to master netting arrangements 1,337 — 1,337 (546) (712) 79 Total liabilities $ 1,337 $ — $ 1,337 $ (546) $ (712) $ 79
Offsetting Liabilities [Table Text Block]	Agreements subject to master netting arrangements with various counterparties, and cash and non-cash collateral posted under such agreements at the end of each period were as follows: Apr 1, 2023 Gross Amounts Not Offset in the Balance Sheet (In Millions) Gross Amounts Recognized Gross Amounts Offset in the Balance Sheet Net Amounts Presented in the Balance Sheet Financial Instruments Cash and Non-Cash Collateral Received or Pledged Net Amount Assets: Derivative assets subject to master netting arrangements $ 966 $ — $ 966 $ (471) $ (495) $ — Reverse repurchase agreements 1,700 — 1,700 — (1,700) — Total assets 2,666 — 2,666 (471) (2,195) — Liabilities: Derivative liabilities subject to master netting arrangements 935 — 935 (471) (392) 72 Total liabilities $ 935 $ — $ 935 $ (471) $ (392) $ 72 Dec 31, 2022 Gross Amounts Not Offset in the Balance Sheet (In Millions) Gross Amounts Recognized Gross Amounts Offset in the Balance Sheet Net Amounts Presented in the Balance Sheet Financial Instruments Cash and Non-Cash Collateral Received or Pledged Net Amount Assets: Derivative assets subject to master netting arrangements $ 1,231 $ — $ 1,231 $ (546) $ (682) $ 3 Reverse repurchase agreements 1,701 — 1,701 — (1,701) — Total assets 2,932 — 2,932 (546) (2,383) 3 Liabilities: Derivative liabilities subject to master netting arrangements 1,337 — 1,337 (546) (712) 79 Total liabilities $ 1,337 $ — $ 1,337 $ (546) $ (712) $ 79
Not Designated as Hedging Instrument [Member]
Derivative [Line Items]
Schedule of Derivative Instruments, Gain (Loss) in Statement of Financial Performance [Table Text Block]	The effects of derivative instruments not designated as hedging instruments on the Consolidated Condensed Statements of Income for each period were as follows: Three Months Ended (In Millions) Location of Gains (Losses) Apr 1, 2023 Apr 2, 2022 Foreign currency contracts Interest and other, net $ 1 $ 158 Interest rate contracts Interest and other, net (34) 94 Other Various 115 (134) Total $ 82 $ 118
Interest and other, net [Member] \| Fair Value Hedging
Derivative [Line Items]
Schedule of Derivative Instruments, Gain (Loss) in Statement of Financial Performance [Table Text Block]	The effects of derivative instruments designated as fair value hedges, recognized in interest and other, net for each period were as follows: Gains (Losses) Recognized in Consolidated Condensed Statements of Income on Derivatives Three Months Ended (In Millions) Apr 1, 2023 Apr 2, 2022 Interest rate contracts $ 192 $ (711) Hedged items (192) 711 Total $ — $ —

Operating Segments (Details)

Operating Segments (Details) - USD ($) $ in Millions	3 Months Ended
Operating Segments (Details) - USD ($) $ in Millions	Apr. 01, 2023	Apr. 02, 2022
Segment Reporting Information [Line Items]
Net revenue	$ 11,715	$ 18,353
Operating Income (Loss)	(1,468)	4,341
Operating Segments
Segment Reporting Information [Line Items]
Net revenue	11,715	18,353
Client Computing Group
Segment Reporting Information [Line Items]
Operating Income (Loss)	520	2,722
Client Computing Group \| Operating Segments
Segment Reporting Information [Line Items]
Net revenue	5,767	9,322
Client Computing Group \| Desktop \| Operating Segments
Segment Reporting Information [Line Items]
Net revenue	1,879	2,641
Client Computing Group \| Notebook \| Operating Segments
Segment Reporting Information [Line Items]
Net revenue	3,407	5,959
Client Computing Group \| Other \| Operating Segments
Segment Reporting Information [Line Items]
Net revenue	481	722
Datacenter and AI
Segment Reporting Information [Line Items]
Operating Income (Loss)	(518)	1,393
Datacenter and AI \| Operating Segments
Segment Reporting Information [Line Items]
Net revenue	3,718	6,074
Network and Edge
Segment Reporting Information [Line Items]
Operating Income (Loss)	(300)	416
Network and Edge \| Operating Segments
Segment Reporting Information [Line Items]
Net revenue	1,489	2,139
Mobileye
Segment Reporting Information [Line Items]
Operating Income (Loss)	123	148
Mobileye \| Operating Segments
Segment Reporting Information [Line Items]
Net revenue	458	394
Intel Foundry Services
Segment Reporting Information [Line Items]
Operating Income (Loss)	(140)	(23)
Intel Foundry Services \| Operating Segments
Segment Reporting Information [Line Items]
Net revenue	118	156
All other
Segment Reporting Information [Line Items]
Operating Income (Loss)	(1,153)	(315)
All other \| Operating Segments
Segment Reporting Information [Line Items]
Net revenue	$ 165	$ 268

Non-Controlling Interests (Deta

Non-Controlling Interests (Details) - USD ($) $ in Millions	3 Months Ended		12 Months Ended
Non-Controlling Interests (Details) - USD ($) $ in Millions	Apr. 01, 2023	Apr. 02, 2022	Dec. 31, 2022
Noncontrolling Interest [Line Items]
Assets	$ 185,303		$ 182,103
Non-controlling interest	2,344		1,863
Less: Net income (loss) attributable to non-controlling interests	(10)	$ 0
Mobileye
Noncontrolling Interest [Line Items]
Net proceeds			1,000
Semiconductor Co-Investment Program, Construction Costs \| Intel and Brookfield
Noncontrolling Interest [Line Items]
Unrecognized commitment	$ 29,000
Arizona Fab
Noncontrolling Interest [Line Items]
Percentage of factory output with the right to purchase	100%
Non-controlling interest	$ 1,300		874
Less: Net income (loss) attributable to non-controlling interests	5	$ 5
Mobileye
Noncontrolling Interest [Line Items]
Non-controlling interest	$ 1,000		$ 1,000
Non-controlling interest percent held by parent	94%		94%
Less: Net income (loss) attributable to non-controlling interests	$ 5
Variable Interest Entity, Primary Beneficiary \| Asset Pledged as Collateral
Noncontrolling Interest [Line Items]
Assets	$ 2,700		$ 1,800
Variable Interest Entity, Primary Beneficiary \| Arizona Fab
Noncontrolling Interest [Line Items]
Interest in variable interest entity	51%
Variable Interest Entity, Not Primary Beneficiary \| Arizona Fab
Noncontrolling Interest [Line Items]
Interest in variable interest entity	49%

Earnings Per Share (Details)

Earnings Per Share (Details) - USD ($) $ / shares in Units, shares in Millions, $ in Millions	3 Months Ended
	Apr. 01, 2023	Apr. 02, 2022
Earnings Per Share [Abstract]
Net income (loss)	$ (2,768)	$ 8,113
Less: Net income (loss) attributable to non-controlling interests	(10)	0
Net income (loss) attributable to Intel	$ (2,758)	$ 8,113
Weighted average shares of common stock outstanding—basic	4,154	4,079
Dilutive effect of employee equity incentive plans (shares)	0	28
Weighted average shares of common stock outstanding—diluted	4,154	4,107
Earnings per share - Basic (in dollars per share)	$ (0.66)	$ 1.99
Earnings per share - Diluted (in dollars per share)	$ (0.66)	$ 1.98

Other Financial Statement Det_3

Other Financial Statement Details - Accounts Receivable (Details) $ in Millions	3 Months Ended
	Apr. 01, 2023 USD ($)
Quarterly Financial Information Disclosure [Abstract]
Accounts receivable sold	$ 500

Other Financial Statement Det_4

Other Financial Statement Details - Inventories (Details) - USD ($) $ in Millions	Apr. 01, 2023	Dec. 31, 2022
Inventory, Net [Abstract]
Raw materials	$ 1,358	$ 1,517
Work in process	7,415	7,565
Finished goods	4,220	4,142
Total inventories	$ 12,993	$ 13,224

Other Financial Statement Det_5

Other Financial Statement Details - Interest and Other, Net (Details) - USD ($) $ in Millions		3 Months Ended
	Dec. 29, 2021	Apr. 01, 2023	Apr. 02, 2022
Other Nonoperating Income (Expense) [Abstract]
Interest income		$ 334	$ 47
Interest expense		(193)	(124)
Other, net		0	1,074
Total interest and other, net		141	997
Interest Costs Capitalized		(363)	(142)
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]
Gains on divestitures		$ 0	1,121
NAND Memory Business
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]
Gains on divestitures	$ 1,000		$ 1,000

Other Financial Statement Det_6

Other Financial Statement Details - Property, Plant and Equipment (Details) - USD ($) $ in Millions	3 Months Ended		12 Months Ended
	Apr. 01, 2023	Apr. 02, 2022	Dec. 31, 2022
Change in Accounting Estimate [Line Items]
Increase to gross margin	$ 4,008	$ 9,244
Decrease in R&D expenses	(4,109)	$ (4,362)
Decrease in ending inventory	(12,993)		$ (13,224)
Estimated useful life
Change in Accounting Estimate [Line Items]
Increase to gross margin	360
Decrease in R&D expenses	100
Decrease in ending inventory	$ 525
Certain production machinery and equipment
Change in Accounting Estimate [Line Items]
Useful life	8 years		5 years

Restructuring and Other Charg_3

Restructuring and Other Charges - Components (Details) - USD ($) $ in Millions	3 Months Ended
	Apr. 01, 2023	Apr. 02, 2022
Restructuring and Related Activities [Abstract]
Employee severance and benefit arrangements	$ (39)	$ 5
Litigation charges and other	77	(1,216)
Asset impairment charges	26	0
Restructuring and other charges	$ 64	$ (1,211)

Restructuring and Other Charg_4

Restructuring and Other Charges - Narrative (Details) - USD ($) $ in Millions	3 Months Ended
	Apr. 01, 2023	Dec. 31, 2022	Apr. 02, 2022
Loss Contingencies [Line Items]
Benefit recorded in litigation charges and other	$ (77)		$ 1,216
EC Fine
Loss Contingencies [Line Items]
Benefit recorded in litigation charges and other		$ 1,200

Restructuring and Other Charg_5

Restructuring and Other Charges - Accrued Restructuring (Details) - USD ($) $ in Millions	3 Months Ended
	Apr. 01, 2023	Apr. 02, 2022
Restructuring Cost and Reserve [Line Items]
Additional accruals	$ 55	$ 17
2022 Restructuring Program
Restructuring Cost and Reserve [Line Items]
Accrued restructuring, beginning balance	873
Adjustments	(41)
Cash payments	(487)
Accrued restructuring, ending balance	$ 345

Investments - Short-term Invest

Investments - Short-term Investments (Details) - USD ($) $ in Millions	3 Months Ended
	Apr. 01, 2023	Apr. 02, 2022	Dec. 31, 2022
Schedule Of Trading Securities And Other Trading Assets [Line Items]
Debt Securities, Realized Gain (Loss)	$ 90	$ 411
Debt Securities, Available-for-sale, Amortized Cost	7,000		$ 10,200
Available-for-sale Securities
Schedule Of Trading Securities And Other Trading Assets [Line Items]
Derivative, Amount of Hedged Item	18,200		$ 16,200
Unrealized Gain (Loss) on Derivatives	$ (102)	$ 377

Investments - Available-for-Sal

Investments - Available-for-Sale Debt Investments (Details) $ in Millions	Apr. 01, 2023 USD ($)
Investments, Debt and Equity Securities [Abstract]
Due in 1 year or less	$ 15,874
Due in 1–2 years	1,805
Due in 2–5 years	4,850
Due after 5 years	734
Instruments not due at a single maturity date1	1,947
Total	$ 25,210

Investments - Equity Investment

Investments - Equity Investments (Details) - USD ($) $ in Millions	3 Months Ended
	Apr. 01, 2023	Apr. 02, 2022	Dec. 31, 2022
Investments, Debt and Equity Securities [Abstract]
Marketable Securities	$ 1,421		$ 1,341
Cost Method Investments	4,598		4,561
Equity Method Investments	10		10
Equity Investments	$ 6,029		$ 5,912
Marketable equity securities subject to trading-volume or market-based restrictions	90%
Marketable equity securities threshold percentage of shares owned resulting in trading volume restrictions	1%
Mark to market on marketable equity securities1	$ 188	$ (430)
Observable price adjustments on non-marketable	10	71
Impairments	(36)	(23)
Other Net Equity Investments	7	4,705
Gain (Loss) on Investments	169	4,323
Net unrealized gains (losses) recognized during the period on equity securities	166	(244)
Less: Net (gains) losses recognized during the period on equity securities sold during the period	(3)	(17)
Net unrealized gains (losses) recognized during the reporting period on equity securities still held at the reporting date	$ 163	$ (261)

Investments - Equity Investme_2

Investments - Equity Investments, Narrative (Details) - USD ($) $ in Millions	3 Months Ended
	Apr. 01, 2023	Apr. 02, 2022
Schedule of Equity Method Investments [Line Items]
Special dividend recognized in sale of equity investments and other	$ 7	$ 4,705
McAfee
Schedule of Equity Method Investments [Line Items]
Gain on sale of equity method investment	$ 4,600

Investments - Bejing Unisoc Tec

Investments - Bejing Unisoc Technology (Details) - USD ($) $ in Millions	3 Months Ended
	Apr. 01, 2023	Apr. 02, 2022
Schedule of Investments [Line Items]
Gains (losses) on equity investments, net	$ 169	$ 4,323

Acquisitions and Divestitures (

Acquisitions and Divestitures (Details) - USD ($) $ / shares in Units, $ in Millions			3 Months Ended		12 Months Ended
	Dec. 29, 2021	Oct. 19, 2020	Apr. 01, 2023	Apr. 02, 2022	Dec. 30, 2023	Dec. 31, 2022	Oct. 31, 2020
Business Acquisition [Line Items]
Proceeds from divestiture			$ 0	$ 6,544
Gains on divestitures			0	1,121
Income Tax Expense (Benefit)			1,610	1,548
Goodwill			27,591			$ 27,591
NAND Memory Business Divestiture
Business Acquisition [Line Items]
Current related party receivable			184
NAND Memory Business
Business Acquisition [Line Items]
Consideration transferred for divestiture of business		$ 9,000
Proceeds from divestiture	$ 7,000
Gains on divestitures	1,000			$ 1,000
Income Tax Expense (Benefit)	$ 495
Maximum exposure annually							$ 500
Maximum exposure							$ 1,500
Nontrade Receivables, Noncurrent			$ 1,900
Forecast \| Affiliated Entity \| NAND Memory Business Divestiture
Business Acquisition [Line Items]
Quarterly expense reimbursement					$ 35
Tower \| Forecast
Business Acquisition [Line Items]
Cash paid per acquiree share (in dollars per share)					$ 53
Total enterprise value					$ 5,400
Termination fee upon failure to obtain required regulatory approvals					$ 353

Borrowings Borrowings - Narrati

Borrowings Borrowings - Narrative (Details) - USD ($)	3 Months Ended
Borrowings Borrowings - Narrative (Details) - USD ($)	Apr. 01, 2023	Apr. 02, 2022
Debt Instrument [Line Items]
Commercial paper outstanding	$ 1,000,000,000
Commercial paper settled in cash	2,930,000,000	$ 0
Proceeds from issuance of debt	10,968,000,000	$ 0
Commercial Paper
Debt Instrument [Line Items]
Authorization to borrow	10,000,000,000
Variable Rate Revolving Credit Facility \| Revolving Credit Facility
Debt Instrument [Line Items]
Variable rate revolving credit facility	5,000,000,000
Senior Notes
Debt Instrument [Line Items]
Face amount of debt issued	$ 11,000,000,000

Fair Value (Detail)

Fair Value (Detail) - USD ($) $ in Millions	Apr. 01, 2023	Dec. 31, 2022
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Reverse repurchase agreements	$ 1,700	$ 1,701
Derivative assets, Fair Value Disclosure	966	1,231
Derivative liabilities, Fair Value Disclosure	935	1,337
Fair Value, Recurring [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Assets, Fair Value Disclosure	29,427	30,392
Liabilities, Fair Value Disclosure	954	1,384
Fair Value, Nonrecurring [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Grants & loans Receivable, Reverse repurchase agreements, CV	459	437
Short-term and Long-term Debt, Fair Value	45,900	34,300
Marketable Equity Securities [Member] \| Fair Value, Recurring [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Investments, Fair Value Disclosure	1,421	1,341
Cash Equivalents [Member] \| Fair Value, Recurring [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Reverse repurchase agreements	1,700	1,301
Cash Equivalents [Member] \| Corporate Debt Securities [Member] \| Fair Value, Recurring [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Investments, Fair Value Disclosure	1,395	856
Cash Equivalents [Member] \| Fixed Income Securities [Member] \| Fair Value, Recurring [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Investments, Fair Value Disclosure	3,983	8,373
Cash Equivalents [Member] \| Government Debt [Member] \| Fair Value, Recurring [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Investments, Fair Value Disclosure	530	0
Short-Term Investments [Member] \| Corporate Debt Securities [Member] \| Fair Value, Recurring [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Investments, Fair Value Disclosure	5,441	5,381
Short-Term Investments [Member] \| Fixed Income Securities [Member] \| Fair Value, Recurring [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Investments, Fair Value Disclosure	5,160	4,925
Short-Term Investments [Member] \| Government Debt [Member] \| Fair Value, Recurring [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Investments, Fair Value Disclosure	8,701	6,888
Other Current Assets [Member] \| Fair Value, Recurring [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Derivative assets, Fair Value Disclosure	1,037	1,264
Loans receivable, Fair Value Disclosure	54	53
Other Long-Term Assets [Member] \| Fair Value, Recurring [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Derivative assets, Fair Value Disclosure	5	10
Other Accrued Liabilities [Member] \| Fair Value, Recurring [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Derivative liabilities, Fair Value Disclosure	439	685
Other Long-Term Liabilities [Member] \| Fair Value, Recurring [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Derivative liabilities, Fair Value Disclosure	515	699
Level 1 [Member] \| Fair Value, Recurring [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Assets, Fair Value Disclosure	3,728	8,484
Liabilities, Fair Value Disclosure	8	111
Level 1 [Member] \| Marketable Equity Securities [Member] \| Fair Value, Recurring [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Investments, Fair Value Disclosure	1,421	1,341
Level 1 [Member] \| Cash Equivalents [Member] \| Fair Value, Recurring [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Reverse repurchase agreements	0	0
Level 1 [Member] \| Cash Equivalents [Member] \| Corporate Debt Securities [Member] \| Fair Value, Recurring [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Investments, Fair Value Disclosure	0	0
Level 1 [Member] \| Cash Equivalents [Member] \| Fixed Income Securities [Member] \| Fair Value, Recurring [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Investments, Fair Value Disclosure	1,806	6,899
Level 1 [Member] \| Cash Equivalents [Member] \| Government Debt [Member] \| Fair Value, Recurring [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Investments, Fair Value Disclosure	233	0
Level 1 [Member] \| Short-Term Investments [Member] \| Corporate Debt Securities [Member] \| Fair Value, Recurring [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Investments, Fair Value Disclosure	0	0
Level 1 [Member] \| Short-Term Investments [Member] \| Fixed Income Securities [Member] \| Fair Value, Recurring [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Investments, Fair Value Disclosure	141	196
Level 1 [Member] \| Short-Term Investments [Member] \| Government Debt [Member] \| Fair Value, Recurring [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Investments, Fair Value Disclosure	49	48
Level 1 [Member] \| Other Current Assets [Member] \| Fair Value, Recurring [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Derivative assets, Fair Value Disclosure	78	0
Loans receivable, Fair Value Disclosure	0	0
Level 1 [Member] \| Other Long-Term Assets [Member] \| Fair Value, Recurring [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Derivative assets, Fair Value Disclosure	0	0
Level 1 [Member] \| Other Accrued Liabilities [Member] \| Fair Value, Recurring [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Derivative liabilities, Fair Value Disclosure	8	111
Level 1 [Member] \| Other Long-Term Liabilities [Member] \| Fair Value, Recurring [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Derivative liabilities, Fair Value Disclosure	0	0
Level 2 [Member] \| Fair Value, Recurring [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Assets, Fair Value Disclosure	25,699	21,908
Liabilities, Fair Value Disclosure	865	1,184
Level 2 [Member] \| Fair Value, Nonrecurring [Member] \| Reported Value Measurement [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Reverse repurchase agreements	0	400
Level 2 [Member] \| Marketable Equity Securities [Member] \| Fair Value, Recurring [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Investments, Fair Value Disclosure	0	0
Level 2 [Member] \| Cash Equivalents [Member] \| Fair Value, Recurring [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Reverse repurchase agreements	1,700	1,301
Level 2 [Member] \| Cash Equivalents [Member] \| Corporate Debt Securities [Member] \| Fair Value, Recurring [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Investments, Fair Value Disclosure	1,395	856
Level 2 [Member] \| Cash Equivalents [Member] \| Fixed Income Securities [Member] \| Fair Value, Recurring [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Investments, Fair Value Disclosure	2,177	1,474
Level 2 [Member] \| Cash Equivalents [Member] \| Government Debt [Member] \| Fair Value, Recurring [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Investments, Fair Value Disclosure	297	0
Level 2 [Member] \| Short-Term Investments [Member] \| Corporate Debt Securities [Member] \| Fair Value, Recurring [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Investments, Fair Value Disclosure	5,441	5,381
Level 2 [Member] \| Short-Term Investments [Member] \| Fixed Income Securities [Member] \| Fair Value, Recurring [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Investments, Fair Value Disclosure	5,019	4,729
Level 2 [Member] \| Short-Term Investments [Member] \| Government Debt [Member] \| Fair Value, Recurring [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Investments, Fair Value Disclosure	8,652	6,840
Level 2 [Member] \| Other Current Assets [Member] \| Fair Value, Recurring [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Derivative assets, Fair Value Disclosure	959	1,264
Loans receivable, Fair Value Disclosure	54	53
Level 2 [Member] \| Other Long-Term Assets [Member] \| Fair Value, Recurring [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Derivative assets, Fair Value Disclosure	5	10
Level 2 [Member] \| Other Accrued Liabilities [Member] \| Fair Value, Recurring [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Derivative liabilities, Fair Value Disclosure	350	485
Level 2 [Member] \| Other Long-Term Liabilities [Member] \| Fair Value, Recurring [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Derivative liabilities, Fair Value Disclosure	515	699
Level 3 [Member] \| Fair Value, Recurring [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Assets, Fair Value Disclosure	0	0
Liabilities, Fair Value Disclosure	81	89
Level 3 [Member] \| Marketable Equity Securities [Member] \| Fair Value, Recurring [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Investments, Fair Value Disclosure	0	0
Level 3 [Member] \| Cash Equivalents [Member] \| Fair Value, Recurring [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Reverse repurchase agreements	0	0
Level 3 [Member] \| Cash Equivalents [Member] \| Corporate Debt Securities [Member] \| Fair Value, Recurring [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Investments, Fair Value Disclosure	0	0
Level 3 [Member] \| Cash Equivalents [Member] \| Fixed Income Securities [Member] \| Fair Value, Recurring [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Investments, Fair Value Disclosure	0	0
Level 3 [Member] \| Cash Equivalents [Member] \| Government Debt [Member] \| Fair Value, Recurring [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Investments, Fair Value Disclosure	0	0
Level 3 [Member] \| Short-Term Investments [Member] \| Corporate Debt Securities [Member] \| Fair Value, Recurring [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Investments, Fair Value Disclosure	0	0
Level 3 [Member] \| Short-Term Investments [Member] \| Fixed Income Securities [Member] \| Fair Value, Recurring [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Investments, Fair Value Disclosure	0	0
Level 3 [Member] \| Short-Term Investments [Member] \| Government Debt [Member] \| Fair Value, Recurring [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Investments, Fair Value Disclosure	0	0
Level 3 [Member] \| Other Current Assets [Member] \| Fair Value, Recurring [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Derivative assets, Fair Value Disclosure	0	0
Loans receivable, Fair Value Disclosure	0	0
Level 3 [Member] \| Other Long-Term Assets [Member] \| Fair Value, Recurring [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Derivative assets, Fair Value Disclosure	0	0
Level 3 [Member] \| Other Accrued Liabilities [Member] \| Fair Value, Recurring [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Derivative liabilities, Fair Value Disclosure	81	89
Level 3 [Member] \| Other Long-Term Liabilities [Member] \| Fair Value, Recurring [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Derivative liabilities, Fair Value Disclosure	$ 0	$ 0

Other Comprehensive Income (L_3

Other Comprehensive Income (Loss), Accumulated Other Comprehensive Income (Loss) (Detail) - USD ($) $ in Millions	3 Months Ended
	Apr. 01, 2023	Apr. 02, 2022	Dec. 31, 2022	Dec. 25, 2021
Accumulated Other Comprehensive Income (Loss) [Line Items]
Cash Flow Hedge Gain (Loss) to be Reclassified within Twelve Months	$ 97
Accumulated other comprehensive income (loss)	100,403	$ 103,136	$ 103,286	$ 95,391
Other comprehensive income (loss)	143	$ (122)
Unrealized holding gains (losses) on available-for-sale investments [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Accumulated other comprehensive income (loss)	(157)		(299)
Other comprehensive income (loss) before reclassifications	53
Amounts reclassified out of accumulated other comprehensive income (loss)	141
Tax effects	(52)
Other comprehensive income (loss)	142
Unrealized holding gains (losses) on derivatives [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Accumulated other comprehensive income (loss)	(258)		(259)
Other comprehensive income (loss) before reclassifications	0
Amounts reclassified out of accumulated other comprehensive income (loss)	1
Tax effects	0
Other comprehensive income (loss)	1
Actuarial gains (losses) [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Accumulated other comprehensive income (loss)	(4)		(4)
Other comprehensive income (loss) before reclassifications	0
Amounts reclassified out of accumulated other comprehensive income (loss)	0
Tax effects	0
Other comprehensive income (loss)	0
Foreign currency translation adjustment [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Accumulated other comprehensive income (loss)	(419)		$ (562)
Other comprehensive income (loss) before reclassifications	53
Amounts reclassified out of accumulated other comprehensive income (loss)	142
Tax effects	(52)
Other comprehensive income (loss)	$ 143

Derivative Financial Instrume_3

Derivative Financial Instruments (Detail) - USD ($) $ in Millions	3 Months Ended		12 Months Ended
	Apr. 01, 2023	Apr. 02, 2022	Dec. 31, 2022
Notional Disclosures [Abstract]
Notional amount	$ 49,495		$ 49,708
Offsetting Derivative Assets [Abstract]
Derivative Assets, Fair Value, Gross Amounts	966		1,231
Derivative Assets Subject to Master Netting Arrangements, Gross Amounts Offset in the Balance Sheet	0		0
Derivative Assets Subject to Master Netting Arrangements, Net Amount Presented in the Balance Sheet	966		1,231
Derivative Assets, Financial Instruments Not Offset in the Balance Sheet	(471)		(546)
Derivative Assets, Cash Collateral Not Offset in the Balance Sheet	(495)		(682)
Derivative Assets Subject to Master Netting Arrangements, Net Amount	0		3
Reverse Repurchase Agreements, Gross Amounts Recognized	1,700		1,701
Reverse Repurchase Agreements, Gross Amounts Offset In The Balance Sheet	0		0
Reverse Repurchase Agreements, Net Amount Presented in the Balance Sheet	1,700		1,701
Reverse Repurchase Agreements, Financial Instruments Not Offset in the Balance Sheet	0		0
Reverse Repurchase Agreements, Cash Collateral Not Offset in the Balance Sheet	(1,700)		(1,701)
Reverse Repurchase Agreements, Net Amount	0		0
Total Assets, Gross Amounts Recognized	2,666		2,932
Total Assets, Gross Amounts Offset in the Balance Sheet	0		0
Total Assets, Net Amounts Presented in the Balance Sheet	2,666		2,932
Total Assets, Financial Instruments, Not Offset in the Balance Sheet	(471)		(546)
Total Assets, Cash and Non Cash Collateral, Not Offset in the Balance Sheet	(2,195)		(2,383)
Total Assets, Net Amount	0		3
Offsetting Derivative Liabilities [Abstract]
Derivative Liabilities, Fair Value, Gross Amounts	935		1,337
Derivative Liabilities Subject to Master Netting Arrangements, Gross Amounts Offset in the Balance Sheet	0		0
Derivative Liabilities Subject to Master Netting Arrangements, Net Amount Presented in the Balance Sheet	935		1,337
Derivative Liabilities, Financial Instruments Not Offset in the Balance Sheet	(471)		(546)
Derivative Liabilities, Cash Collateral Not Offset in the Balance Sheet	(392)		(712)
Derivative Liabilities Subject to Master Netting Arrangements, Net Amount	72		79
Effect of Fair Value Hedges on Results of Operations [Abstract]
Change in Unrealized Gain (Loss) on Hedged Item in Fair Value Hedge	(192)	$ 711
Net Change In Unrealized Gain (Loss) Recognized In Income Statement On Fair Value Hedging Instruments And On Hedged Item In Fair Value Hedge	0	0
Assets
Offsetting Derivative Assets [Abstract]
Derivative Assets, Fair Value, Gross Amounts	1,042		1,274
Liabilities
Offsetting Derivative Liabilities [Abstract]
Derivative Liabilities, Fair Value, Gross Amounts	954		1,384
Designated as Hedging Instrument [Member] \| Assets
Offsetting Derivative Assets [Abstract]
Derivative Assets, Fair Value, Gross Amounts	187		142
Designated as Hedging Instrument [Member] \| Liabilities
Offsetting Derivative Liabilities [Abstract]
Derivative Liabilities, Fair Value, Gross Amounts	770		1,067
Not Designated as Hedging Instrument [Member]
Derivative Instruments Not Designated as Hedging Instruments [Abstract]
Gains (Losses) Recognized in Income On Derivatives	82	118
Not Designated as Hedging Instrument [Member] \| Assets
Offsetting Derivative Assets [Abstract]
Derivative Assets, Fair Value, Gross Amounts	855		1,132
Not Designated as Hedging Instrument [Member] \| Liabilities
Offsetting Derivative Liabilities [Abstract]
Derivative Liabilities, Fair Value, Gross Amounts	184		317
Foreign currency contracts
Notional Disclosures [Abstract]
Notional amount	30,847		31,603
Derivative Instruments, Gain (Loss) Reclassified from Accumulated OCI into Income, Effective Portion, Net [Abstract]
Before-tax net gains (losses) attributed to cash flow hedges, recognized in other comprehensive income (loss)	53	115
Foreign currency contracts \| Designated as Hedging Instrument [Member] \| Assets
Offsetting Derivative Assets [Abstract]
Derivative Assets, Fair Value, Gross Amounts	187		142
Foreign currency contracts \| Designated as Hedging Instrument [Member] \| Liabilities
Offsetting Derivative Liabilities [Abstract]
Derivative Liabilities, Fair Value, Gross Amounts	185		290
Foreign currency contracts \| Not Designated as Hedging Instrument [Member]
Derivative Instruments Not Designated as Hedging Instruments [Abstract]
Gains (Losses) Recognized in Income On Derivatives	1	158
Foreign currency contracts \| Not Designated as Hedging Instrument [Member] \| Assets
Offsetting Derivative Assets [Abstract]
Derivative Assets, Fair Value, Gross Amounts	537		866
Foreign currency contracts \| Not Designated as Hedging Instrument [Member] \| Liabilities
Offsetting Derivative Liabilities [Abstract]
Derivative Liabilities, Fair Value, Gross Amounts	156		194
Interest rate contracts
Notional Disclosures [Abstract]
Notional amount	16,590		16,011
Effect of Fair Value Hedges on Results of Operations [Abstract]
Change in Unrealized Gain (Loss) on Fair Value Hedging Instruments	192	(711)
Interest rate contracts \| Designated as Hedging Instrument [Member] \| Assets
Offsetting Derivative Assets [Abstract]
Derivative Assets, Fair Value, Gross Amounts	0		0
Interest rate contracts \| Designated as Hedging Instrument [Member] \| Liabilities
Offsetting Derivative Liabilities [Abstract]
Derivative Liabilities, Fair Value, Gross Amounts	585		777
Interest rate contracts \| Not Designated as Hedging Instrument [Member]
Derivative Instruments Not Designated as Hedging Instruments [Abstract]
Gains (Losses) Recognized in Income On Derivatives	(34)	94
Interest rate contracts \| Not Designated as Hedging Instrument [Member] \| Assets
Offsetting Derivative Assets [Abstract]
Derivative Assets, Fair Value, Gross Amounts	240		266
Interest rate contracts \| Not Designated as Hedging Instrument [Member] \| Liabilities
Offsetting Derivative Liabilities [Abstract]
Derivative Liabilities, Fair Value, Gross Amounts	20		12
Other
Notional Disclosures [Abstract]
Notional amount	2,058		2,094
Other \| Not Designated as Hedging Instrument [Member]
Derivative Instruments Not Designated as Hedging Instruments [Abstract]
Gains (Losses) Recognized in Income On Derivatives	115	$ (134)
Other \| Not Designated as Hedging Instrument [Member] \| Assets
Offsetting Derivative Assets [Abstract]
Derivative Assets, Fair Value, Gross Amounts	78		0
Other \| Not Designated as Hedging Instrument [Member] \| Liabilities
Offsetting Derivative Liabilities [Abstract]
Derivative Liabilities, Fair Value, Gross Amounts	8		111
Interest Rate Swap \| Long-term Debt \| Fair Value Hedging
Derivative [Line Items]
Derivative, Amount of Hedged Item	12,000		12,000
Derivative, Fair Value, Net	(11,413)		(11,221)
Derivative Instruments Not Designated as Hedging Instruments [Abstract]
Gains (Losses) Recognized in Income On Derivatives	$ 584		$ 776

Contingencies (Detail)

Contingencies (Detail) - USD ($) $ in Millions	3 Months Ended
Contingencies (Detail) - USD ($) $ in Millions	Apr. 01, 2023	Apr. 02, 2022
Loss Contingencies [Line Items]
Finance lease prepayments	$ 15	$ 299